Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin versus misoprostol for prevention of postpartum haemorrhage after vaginal delivery
PACTR202409648302665Completed
- Sponsor
- John Egede
- Start
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of oxytocin and misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by John Egede. Primary endpoints: Estimated postpartum blood loss and Incidence of postpartum haemorrhage. Started Jan 2016; status: completed.
02
Drugs
oxytocinmisoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202409648302665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202409648302665.